Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enthesitis-Related Arthritis, Juvenile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06663332
What this trial is testing

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Who this might be right for
Crohns DiseaseColitis, UlcerativeArthritis, Psoriatic+1 more
Janssen Research & Development, LLC 196
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Large-scale testing (Phase 3)Study completedNCT03031782
What this trial is testing

Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis-related Arthritis
Novartis Pharmaceuticals 86
Not applicableUnknownNCT02684695
What this trial is testing

Juvenile Arthritis Quantitative Imaging

Who this might be right for
Arthritis, Juvenile IdiopathicEnthesitis-Related Arthritis, Juvenile
University College London Hospitals 200
Early research (Phase 1)Looking for participantsNCT06751238
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Who this might be right for
Juvenile Psoriatic Arthritis
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Looking for participantsNCT04804553
What this trial is testing

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

Who this might be right for
Active Juvenile Psoriatic Arthritis
Amgen 60
Not applicableNot Yet RecruitingNCT06766552
What this trial is testing

A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

Who this might be right for
Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)Nr-axSpA+5 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 10,000
Large-scale testing (Phase 3)Looking for participantsNCT06869551
What this trial is testing

Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Who this might be right for
Juvenile Psoriatic Arthritis
Bristol-Myers Squibb 60
Large-scale testing (Phase 3)Study completedNCT01421069
What this trial is testing

Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Juvenile Idiopahtic Arthritis
Pfizer 109
Large-scale testing (Phase 3)Study completedNCT01550003
What this trial is testing

Pediatric Arthritis Study of Certolizumab Pegol

Who this might be right for
Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
UCB BIOSCIENCES GmbH 193